Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Stealth Biotherapeutics Corp Ads (MITO)

1.81   0.02 (1.12%) 08-14 16:00
Open: 1.8 Pre. Close: 1.79
High: 1.83 Low: 1.7797
Volume: 124,604 Market Cap: 90M
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate, Elamipretide, has the potential to treat rare genetic and common age-related mitochondrial diseases. The company's product candidates include SBT-20, a small peptide that targets and binds reversibly to cardiolipin, stabilizing mitochondrial structure, and function under conditions of oxidative stress; and SBT-272, a lead discovery pipeline compound, evaluating for rare neurodegenerative diseases, such as amyotrophic lateral sclerosis. Stealth BioTherapeutics Corp was founded in 2006 and is based in George Town, the Cayman Islands.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.831 - 1.842 1.842 - 1.853
Low: 1.754 - 1.767 1.767 - 1.779
Close: 1.79 - 1.809 1.809 - 1.828

Technical analysis

as of: 2020-08-14 4:32:16 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.57     One year: 2.92
Support: Support1: 1.72    Support2: 1.43
Resistance: Resistance1: 2.20    Resistance2: 2.50
Pivot: 1.99
Moving Average: MA(5): 1.85     MA(20): 1.96
MA(100): 1.83     MA(250): 4.13
MACD: MACD(12,26): -0.02     Signal(9): 0.01
Stochastic oscillator: %K(14,3): 6.84     %D(3): 9.15
RSI: RSI(14): 41.30
52-week: High: 14.41  Low: 0.90  Change(%): -84.3
Average Vol(K): 3-Month: 16392  10-Days: 20258

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
MITO has closed above bottom band by 17.7%. Bollinger Bands are 20.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 26 Jun 2020
The Forecast Just Changed on Stealth BioTherapeutics Corp (NASDAQ:MITO) - The Oracle Dispatch

Thu, 07 May 2020
Stealth BioTherapeutics Reports First Quarter 2020 Financial Results and Recent Business Highlights - PRNewswire

Wed, 22 Apr 2020
Stealth BioTherapeutics Corp (MITO) Shares March Higher, Can It Continue? - Yahoo Finance

Mon, 13 Apr 2020
Stealth Biotherapeutics Announces $20 Million Financing to Advance Development of Elamipretide and Pipeline - BioSpace

Tue, 07 Apr 2020
Investors Who Bought Stealth BioTherapeutics (NASDAQ:MITO) Shares A Year Ago Are Now Down 91% - Yahoo Finance

Wed, 01 Apr 2020
Stealth BioTherapeutics Reports Fiscal Year 2019 Financial Results And Recent Business Highlights - PRNewswire

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 49
Shares Float (M) 6
% Held by Insiders
% Held by Institutions 14.03
Shares Short (K) 19
Shares Short P. Month (K) 11

Stock Financials

EPS -1.231
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.070
Profit Margin -209.09
Operating Margin -200.95
Return on Assets (ttm) -50.4
Return on Equity (ttm) -242.6
Qtrly Rev. Growth
Gross Profit (p.s.) 0.428
Sales Per Share 0.428
EBITDA (p.s.) -0.854
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -1.47
PEG Ratio
Price to Book value 25.86
Price to Sales 4.23
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.